GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+28.79%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$228M
AUM Growth
+$228M
(-1.9%)
Cap. Flow
-$41.8M
Cap. Flow
% of AUM
-18.32%
Top 10 Holdings %
Top 10 Hldgs %
78.68%
Holding
37
New
–
Increased
9
Reduced
3
Closed
11
Top Buys
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$9.27M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$8.22M |
| 3 |
Arcturus Therapeutics
ARCT
|
$5.07M |
| 4 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$4.49M |
| 5 |
Vanda Pharmaceuticals
VNDA
|
$3.59M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$27.3M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$14.3M |
| 3 |
RLYP
RELYPSA INC COM
RLYP
|
$14.2M |
| 4 |
MDCO
Medicines Co
MDCO
|
$5.69M |
| 5 |
STML
Stemline Therapeutics, Inc.
STML
|
$4.2M |
Sector Composition
| 1 | Healthcare | 60.74% |
| 2 | Technology | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WINT
26
DELISTED
Windtree Therapeutics Inc
WINT
| – | – |
-2,530,532
| Closed | -$759K |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| – | – |
-150,000
| Closed | -$5.69M |
|
|
STML
28
DELISTED
Stemline Therapeutics, Inc.
STML
| – | – |
-475,200
| Closed | -$4.2M |
|
|
GWPH
29
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
0
| – | – |
|
|
FLXN
30
DELISTED
Flexion Therapeutics, Inc.
FLXN
| – | – |
0
| – | – |
|
|
ATRS
31
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-1,018,627
| Closed | -$1.73M |
|
|
ALBO
32
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – |
-3,316,966
| Closed | -$1.46M |
|
|
MTEM
33
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
0
| – | – |
|
|
ALIM
34
DELISTED
Alimera Sciences, Inc.
ALIM
| – | – |
-1,683,162
| Closed | -$3.72M |
|
35
Neurogene
NGNE
$284M
| – | – |
-100,000
| Closed | -$1.41M |
|
36
MannKind Corp
MNKD
$1.69B
| – | – |
0
| – | – |
|
37
Cytokinetics
CYTK
$5.98B
| – | – |
0
| – | – |
|